The Antibody-Drug Conjugate (ADC) IMGN779 Is Highly Active in Vitro and in Vivo Against Acute Myeloid Leukemia (AML) with FLT3-ITD Mutations

被引：25
|
作者：
Whiteman, Kathleen R. [1 ]
Noordhuis, Paul [2 ]
Walker, Russell [1 ]
Watkins, Krystal [1 ]
Kovtun, Yelena [1 ]
Harvey, Lauren [1 ]
Wilhelm, Alan [1 ]
Johnson, Holly [1 ]
Schuurhuis, Gerrit Jan [2 ]
Ossenkoppele, Gert J. [2 ]
Lutz, Robert J. [1 ]
机构：
[1] ImmunoGen Inc, Waltham, MA USA
[2] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
10.1182/blood.V124.21.2321.2321
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Plasma pharmacokinetics and tumor accumulation in mice of IMGN779, an antibody-drug conjugate for acute myeloid leukemia
    Lai, Katharine C.
    Shah, Prerak
    Sikka, Surina
    Sun, XiuXia
    LaLeau, Rassol
    Whiteman, Kathleen R.
    Johnson-Modafferi, Holly
    Wilhelm, Alan
    Audette, Charlene
    Wang, Lintao
    Bogalhas, Megan E.
    Keating, Thomas A.
    Chari, Ravi
    CANCER RESEARCH, 2015, 75
  • [2] IMGN779: A CD33-TARGETED ANTIBODY-DRUG CONJUGATE (ADC) UTILIZING A NOVEL DNA ALKYLATOR, DGN462, IS HIGHLY ACTIVE IN VITRO AGAINST PRIMARY PATIENT AML CELLS AND IN VIVO AGAINST AML XENOGRAFTS IN MICE
    Whiteman, K. R.
    Noordhuis, P.
    Schuurhuis, G. J.
    Kovtun, Y.
    Harvey, L.
    Audette, C.
    Maloney, E.
    Johnson, H. A.
    Fishkin, N.
    Ossenkoppele, G. J.
    Lutz, R. J.
    HAEMATOLOGICA, 2014, 99 : 293 - 293
  • [3] Synergistic antileukemic activity of the antibody-drug conjugate (IMGN779) combined with PARP inhibition in preclinical human acute myeloid leukemia models
    Fritz, Claire
    Portwood, Scott M.
    Adams, Julie
    Wang, Eunice S.
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Combining IMGN779, a Novel Anti-CD33 Antibody-Drug Conjugate (ADC), with the PARP Inhibitor, Olaparib, Results in Enhanced Anti-Tumor Activity in Preclinical Acute Myeloid Leukemia (AML) Models
    Portwood, Scott
    Puchalski, Robert A.
    Walker, Russell M.
    Wang, Eunice S.
    BLOOD, 2016, 128 (22)
  • [5] IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate (ADC) Demonstrates Initial Antileukemia Activity in Patients with Relapsed or Refractory Acute Myeloid Leukemia
    Cortes, Jorge E.
    Traer, Elie
    Wang, Eunice S.
    Erba, Harry P.
    Blum, William
    Arana-Yi, Cecilia
    Sloss, Callum M.
    Culm-Merdek, Kerry
    Towles, Jeanette
    Zweidler-McKay, Patrick A.
    DeAngelo, Daniel J.
    BLOOD, 2017, 130
  • [6] Quizartinib with decitabine and venetoclax (triplet) is highly active in patients with FLT3-ITD mutated acute myeloid leukemia (AML).
    Yilmaz, Musa
    Kantarjian, Hagop M.
    Muftuoglu, Muharrem
    Kadia, Tapan M.
    Konopleva, Marina
    Borthakur, Gautam
    Dinardo, Courtney Denton
    Pemmaraju, Naveen
    Short, Nicholas James
    Alvarado, Yesid
    Montalban-Bravo, Guillermo
    Jurisprudenica, Carissa
    Pike, Allison
    Ohanian, Maro
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Ruvolo, Vivian
    Ravandi, Farhad
    Andreeff, Michael
    Daver, Naval Guastad
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Maturing Clinical Profile of IMGN779, a Next-Generation CD33-Targeting Antibody-Drug Conjugate, in Patients with Relapsed or Refractory Acute Myeloid Leukemia
    Cortes, Jorge E.
    DeAngelo, Daniel J.
    Erba, Harry P.
    Traer, Elie
    Papadantonakis, Nikolaos
    Arana-Yi, Cecilia
    Blum, William
    Sloss, Callum M.
    Culm-Merdek, Kerry
    Zweidler-McKay, Patrick A.
    Wang, Eunice S.
    BLOOD, 2018, 132
  • [8] Molecular analysis of different FLT3-ITD mutations in acute myeloid leukemia
    Blau, Olga
    Berenstein, Rimma
    Sindram, Annette
    Blau, Igor Wolfgang
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 145 - 152
  • [9] Secondary resistance to sorafenib in two patients with acute myeloid leukemia (AML) harboring FLT3-ITD mutations
    Scholl, Sebastian
    Spies-Weisshart, Baerbel
    Klink, Anne
    Muegge, Lars-Olof
    Fricke, Hans-Joerg
    Hochhaus, Andreas
    ANNALS OF HEMATOLOGY, 2011, 90 (04) : 473 - 475
  • [10] TERMINAL DEOXYNUCLEOTIDYL TRANFERASE (TDT) EXPRESSION IS ASSOCIATED WITH FLT3-ITD MUTATIONS IN ACUTE MYELOID LEUKEMIA (AML)
    De Bellis, E.
    Ottone, T.
    Mercante, L.
    Falconi, G.
    Cugini, E.
    Consalvo, M. I.
    Travaglini, S.
    Paterno, G.
    Piciocchi, A.
    Rossi, E. L. Lindfors
    Gurnari, C.
    Maurillo, L.
    Buccisano, F.
    Arcese, W.
    Voso, M. T.
    HAEMATOLOGICA, 2020, 105 : S89 - S90
12345